Hugues Bourgeois

Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients

Fabrice Denis, Claire Lethrosne, N. Pourel et al. · JNCI Journal of the National Cancer Institute · 2017 · 505 citations · Full text

Medicine, Oncology, Cancer Symptom Management +15

Trastuzumab for Patients With Axillary-Node–Positive Breast Cancer: Results of the FNCLCC-PACS 04 Trial

M. Spielmann, Henri Roché, T. Delozier et al. · Journal of Clinical Oncology · 2009 · 299 citations

Medicine, Oncology, Pharmacotherapy +17

Randomized Phase III Trial of Topotecan Following Carboplatin and Paclitaxel in First-line Treatment of Advanced Ovarian Cancer: A Gynecologic Cancer Intergroup Trial of the AGO-OVAR and GINECO

Jacobus Pfisterer, B. Weber, Rainer Kimmig et al. · JNCI Journal of the National Cancer Institute · 2006 · 209 citations

Medicine, Gynecology, Oncology +16

Proven bioequivalence of blood exposure between vinorelbine 80 mg/m² oral and 30 mg/m² IV doses in cancer patients

Hugues Bourgeois, Jan B. Vermorken, G. Dark et al. · Journal of Clinical Oncology · 2005 · 179 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +15

Efficacy of Circulating Tumor Cell Count–Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer

François‐Clément Bidard, William Jacot, Nicolas Kiavué et al. · JAMA Oncology · 2020 · 178 citations · Full text

Medicine, Oncology, Chemotherapy +16